Clinical Trial Investigator Prospecting Brief

Role: Principal Clinical Account Executive with fifteen years of experience in biopharma site selection and investigator relations.

Context

• Life sciences sponsor: {{sponsor_name}}
• Core disease indication: {{therapeutic_area}}
• Prospective trial site: {{target_institution}}
• Clinical development stage: {{current_trial_phase}}
• Protocol requirements: {{protocol_complexity}}
• Key institutional stakeholder: {{decision_maker_role}}

Task

Generate a tailored clinical investigator prospecting brief that equips the field team to initiate compliant, scientifically grounded partnership discussions with key decision-makers at the target institution.

Method

1. Review the clinical scope of {{therapeutic_area}} against the operational capabilities of {{target_institution}}.
2. Analyze the specific protocol friction points implied by {{protocol_complexity}} and identify how {{sponsor_name}} can mitigate site burden.
3. Map the clinical interests and clinical trial bandwidth of the {{decision_maker_role}}.
4. Evaluate competing or active studies in {{current_trial_phase}} within the same indication at {{target_institution}}.
5. Formulate three distinct, protocol-aligned conversational hooks that emphasize patient recruitment feasibility.
6. Detail two operational value propositions addressing coordinator workflow and institutional overhead.
7. Draft an initial outreach script tailored to the compliance boundaries of clinical trial feasibility discussions.

Constraints

• MUST cite specific operational requirements related to {{protocol_complexity}} in every conversation hook.
• MUST NOT make promotional efficacy claims that violate GCP or regulatory pre-trial disclosure guidelines.
• Keep the outreach recommendations strictly focused on investigator capability and site readiness.
• Limit total brief length to under 650 words.

Output format

Provide the brief using these exact section headers:

• Site Overview & Indication Fit (max 100 words)
• Investigator Profile & Protocol Alignment (3-4 bullets)
• Tailored Value Angles (3 numbered points)
• Initial Outreach Copy (1 email template, under 150 words)

Self-review

1. Did I address the specific role of the {{decision_maker_role}} accurately?
2. Are all regulatory and protocol feasibility considerations free of off-label or unsubstantiated claims?
3. Does the outreach copy directly reference the operational nuances of {{protocol_complexity}}?